Global Oxfendazole ﾂ鮓ｹﾔｭｴｴ 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Publication ID:

GIR122403741

Publication Date:

December 10, 2024

Pages:

Publisher:

GIR

Countries:

Global [1]

USD 3,480.00

Specialty Chemicals [2]

Manufacturing (Chemicals) [3]

Chemicals [4]

Description:

The global Oxfendazole market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
Oxfendazole is a broad spectrum benzimidazole anthelmintic. Its main use is for protecting livestock against roundworm, strongyles and pinworms. Oxfendazole is the sulfoxide metabolite of fenbendazole. Oxfendazole is an anthelmintic (wormer) compound used in veterinary practice.
The report includes an overview of the development of the Oxfendazole industry chain, the market status of Powder (竕･98%, 竕･99%), Solution (竕･98%, 竕･99%), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Oxfendazole.
Regionally, the report analyzes the Oxfendazole markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Oxfendazole market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Oxfendazole market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Oxfendazole industry.
The report involves analyzing the market at a macro level:
ﾂ鮓ｹﾔｭｴｴ Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (Ton), revenue generated, and market share of different by Type (e.g., 竕･98%, 竕･99%).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Oxfendazole market.
Regional Analysis: The report involves examining the Oxfendazole market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
ﾂ鮓ｹﾔｭｴｴ Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Oxfendazole market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Oxfendazole:
Company Analysis: Report covers individual Oxfendazole manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Oxfendazole This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Powder, Solution).
Technology Analysis: Report covers specific technologies relevant to Oxfendazole. It assesses the current state, advancements, and potential future developments in Oxfendazole areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Oxfendazole market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
ﾂ鮓ｹﾔｭｴｴ Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
ﾂ鮓ｹﾔｭｴｴ Segmentation
Oxfendazole market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
ﾂ鮓ｹﾔｭｴｴ segment by Type
竕･98%
竕･99%
Other
ﾂ鮓ｹﾔｭｴｴ segment by Application
Powder
Solution
Major players covered
Alivira Animal Health
Bazayan
Wuhan Dahua Pharmaceutical
Jiangsu Baozong & Baoda Pharmachem
Shanxi Hanjiang pharmaceutical
Lasa Laboratory
Jiangsu Quality Horizons Pharmtech
ﾂ鮓ｹﾔｭｴｴ segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Oxfendazole product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Oxfendazole, with price, sales, revenue and global market share of Oxfendazole from 2019 to 2024.
Chapter 3, the Oxfendazole competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Oxfendazole breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Oxfendazole market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Oxfendazole.
Chapter 14 and 15, to describe Oxfendazole sales channel, distributors, customers, research findings and conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.

Table Of Contents:

1 ﾂ鮓ｹﾔｭｴｴ Overview
1.1 Product Overview and Scope of Oxfendazole
1.2 ﾂ鮓ｹﾔｭｴｴ Estimation Caveats and Base Year
1.3 ﾂ鮓ｹﾔｭｴｴ Analysis by Type
1.3.1 Overview: Global Oxfendazole Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 竕･98%
1.3.3 竕･99%
1.3.4 Other
1.4 ﾂ鮓ｹﾔｭｴｴ Analysis by Application
1.4.1 Overview: Global Oxfendazole Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Powder
1.4.3 Solution
1.5 Global Oxfendazole ﾂ鮓ｹﾔｭｴｴ Size & Forecast
1.5.1 Global Oxfendazole Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Oxfendazole Sales Quantity (2019-2030)
1.5.3 Global Oxfendazole Average Price (2019-2030)
2 Manufacturers Profiles
2.1 Alivira Animal Health
2.1.1 Alivira Animal Health Details
2.1.2 Alivira Animal Health Major Business
2.1.3 Alivira Animal Health Oxfendazole Product and Services
2.1.4 Alivira Animal Health Oxfendazole Sales Quantity, Average Price, Revenue, Gross Margin and ﾂ鮓ｹﾔｭｴｴ Share (2019-2024)
2.1.5 Alivira Animal Health Recent Developments/Updates
2.2 Bazayan
2.2.1 Bazayan Details
2.2.2 Bazayan Major Business
2.2.3 Bazayan Oxfendazole Product and Services
2.2.4 Bazayan Oxfendazole Sales Quantity, Average Price, Revenue, Gross Margin and ﾂ鮓ｹﾔｭｴｴ Share (2019-2024)
2.2.5 Bazayan Recent Developments/Updates
2.3 Wuhan Dahua Pharmaceutical
2.3.1 Wuhan Dahua Pharmaceutical Details
2.3.2 Wuhan Dahua Pharmaceutical Major Business
2.3.3 Wuhan Dahua Pharmaceutical Oxfendazole Product and Services
2.3.4 Wuhan Dahua Pharmaceutical Oxfendazole Sales Quantity, Average Price, Revenue, Gross Margin and ﾂ鮓ｹﾔｭｴｴ Share (2019-2024)
2.3.5 Wuhan Dahua Pharmaceutical Recent Developments/Updates
2.4 Jiangsu Baozong & Baoda Pharmachem
2.4.1 Jiangsu Baozong & Baoda Pharmachem Details
2.4.2 Jiangsu Baozong & Baoda Pharmachem Major Business
2.4.3 Jiangsu Baozong & Baoda Pharmachem Oxfendazole Product and Services
2.4.4 Jiangsu Baozong & Baoda Pharmachem Oxfendazole Sales Quantity, Average Price, Revenue, Gross Margin and ﾂ鮓ｹﾔｭｴｴ Share (2019-2024)
2.4.5 Jiangsu Baozong & Baoda Pharmachem Recent Developments/Updates
2.5 Shanxi Hanjiang pharmaceutical
2.5.1 Shanxi Hanjiang pharmaceutical Details
2.5.2 Shanxi Hanjiang pharmaceutical Major Business
2.5.3 Shanxi Hanjiang pharmaceutical Oxfendazole Product and Services
2.5.4 Shanxi Hanjiang pharmaceutical Oxfendazole Sales Quantity, Average Price, Revenue, Gross Margin and ﾂ鮓ｹﾔｭｴｴ Share (2019-2024)
2.5.5 Shanxi Hanjiang pharmaceutical Recent Developments/Updates
2.6 Lasa Laboratory
2.6.1 Lasa Laboratory Details
2.6.2 Lasa Laboratory Major Business
2.6.3 Lasa Laboratory Oxfendazole Product and Services
2.6.4 Lasa Laboratory Oxfendazole Sales Quantity, Average Price, Revenue, Gross Margin and ﾂ鮓ｹﾔｭｴｴ Share (2019-2024)
2.6.5 Lasa Laboratory Recent Developments/Updates
2.7 Jiangsu Quality Horizons Pharmtech
2.7.1 Jiangsu Quality Horizons Pharmtech Details
2.7.2 Jiangsu Quality Horizons Pharmtech Major Business
2.7.3 Jiangsu Quality Horizons Pharmtech Oxfendazole Product and Services
2.7.4 Jiangsu Quality Horizons Pharmtech Oxfendazole Sales Quantity, Average Price, Revenue, Gross Margin and ﾂ鮓ｹﾔｭｴｴ Share (2019-2024)
2.7.5 Jiangsu Quality Horizons Pharmtech Recent Developments/Updates
3 Competitive Environment: Oxfendazole by Manufacturer
3.1 Global Oxfendazole Sales Quantity by Manufacturer (2019-2024)
3.2 Global Oxfendazole Revenue by Manufacturer (2019-2024)
3.3 Global Oxfendazole Average Price by Manufacturer (2019-2024)
3.4 ﾂ鮓ｹﾔｭｴｴ Share Analysis (2023)
3.4.1 Producer Shipments of Oxfendazole by Manufacturer Revenue ($MM) and ﾂ鮓ｹﾔｭｴｴ Share (%): 2023
3.4.2 Top 3 Oxfendazole Manufacturer ﾂ鮓ｹﾔｭｴｴ Share in 2023
3.4.2 Top 6 Oxfendazole Manufacturer ﾂ鮓ｹﾔｭｴｴ Share in 2023
3.5 Oxfendazole ﾂ鮓ｹﾔｭｴｴ: Overall Company Footprint Analysis
3.5.1 Oxfendazole ﾂ鮓ｹﾔｭｴｴ: Region Footprint
3.5.2 Oxfendazole ﾂ鮓ｹﾔｭｴｴ: Company Product Type Footprint
3.5.3 Oxfendazole ﾂ鮓ｹﾔｭｴｴ: Company Product Application Footprint
3.6 New ﾂ鮓ｹﾔｭｴｴ Entrants and Barriers to ﾂ鮓ｹﾔｭｴｴ Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Oxfendazole ﾂ鮓ｹﾔｭｴｴ Size by Region
4.1.1 Global Oxfendazole Sales Quantity by Region (2019-2030)
4.1.2 Global Oxfendazole Consumption Value by Region (2019-2030)
4.1.3 Global Oxfendazole Average Price by Region (2019-2030)
4.2 North America Oxfendazole Consumption Value (2019-2030)
4.3 Europe Oxfendazole Consumption Value (2019-2030)
4.4 Asia-Pacific Oxfendazole Consumption Value (2019-2030)
4.5 South America Oxfendazole Consumption Value (2019-2030)
4.6 Middle East and Africa Oxfendazole Consumption Value (2019-2030)
5 ﾂ鮓ｹﾔｭｴｴ Segment by Type
5.1 Global Oxfendazole Sales Quantity by Type (2019-2030)
5.2 Global Oxfendazole Consumption Value by Type (2019-2030)
5.3 Global Oxfendazole Average Price by Type (2019-2030)
6 ﾂ鮓ｹﾔｭｴｴ Segment by Application
6.1 Global Oxfendazole Sales Quantity by Application (2019-2030)
6.2 Global Oxfendazole Consumption Value by Application (2019-2030)
6.3 Global Oxfendazole Average Price by Application (2019-2030)
7 North America
7.1 North America Oxfendazole Sales Quantity by Type (2019-2030)
7.2 North America Oxfendazole Sales Quantity by Application (2019-2030)
7.3 North America Oxfendazole ﾂ鮓ｹﾔｭｴｴ Size by Country
7.3.1 North America Oxfendazole Sales Quantity by Country (2019-2030)
7.3.2 North America Oxfendazole Consumption Value by Country (2019-2030)
7.3.3 United States ﾂ鮓ｹﾔｭｴｴ Size and Forecast (2019-2030)
7.3.4 Canada ﾂ鮓ｹﾔｭｴｴ Size and Forecast (2019-2030)
7.3.5 Mexico ﾂ鮓ｹﾔｭｴｴ Size and Forecast (2019-2030)
8 Europe
8.1 Europe Oxfendazole Sales Quantity by Type (2019-2030)
8.2 Europe Oxfendazole Sales Quantity by Application (2019-2030)
8.3 Europe Oxfendazole ﾂ鮓ｹﾔｭｴｴ Size by Country
8.3.1 Europe Oxfendazole Sales Quantity by Country (2019-2030)
8.3.2 Europe Oxfendazole Consumption Value by Country (2019-2030)
8.3.3 Germany ﾂ鮓ｹﾔｭｴｴ Size and Forecast (2019-2030)
8.3.4 France ﾂ鮓ｹﾔｭｴｴ Size and Forecast (2019-2030)
8.3.5 United Kingdom ﾂ鮓ｹﾔｭｴｴ Size and Forecast (2019-2030)
8.3.6 Russia ﾂ鮓ｹﾔｭｴｴ Size and Forecast (2019-2030)
8.3.7 Italy ﾂ鮓ｹﾔｭｴｴ Size and Forecast (2019-2030)
9 Asia-Pacific
9.1 Asia-Pacific Oxfendazole Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Oxfendazole Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Oxfendazole ﾂ鮓ｹﾔｭｴｴ Size by Region
9.3.1 Asia-Pacific Oxfendazole Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Oxfendazole Consumption Value by Region (2019-2030)
9.3.3 China ﾂ鮓ｹﾔｭｴｴ Size and Forecast (2019-2030)
9.3.4 Japan ﾂ鮓ｹﾔｭｴｴ Size and Forecast (2019-2030)
9.3.5 Korea ﾂ鮓ｹﾔｭｴｴ Size and Forecast (2019-2030)
9.3.6 India ﾂ鮓ｹﾔｭｴｴ Size and Forecast (2019-2030)
9.3.7 Southeast Asia ﾂ鮓ｹﾔｭｴｴ Size and Forecast (2019-2030)
9.3.8 Australia ﾂ鮓ｹﾔｭｴｴ Size and Forecast (2019-2030)
10 South America
10.1 South America Oxfendazole Sales Quantity by Type (2019-2030)
10.2 South America Oxfendazole Sales Quantity by Application (2019-2030)
10.3 South America Oxfendazole ﾂ鮓ｹﾔｭｴｴ Size by Country
10.3.1 South America Oxfendazole Sales Quantity by Country (2019-2030)
10.3.2 South America Oxfendazole Consumption Value by Country (2019-2030)
10.3.3 Brazil ﾂ鮓ｹﾔｭｴｴ Size and Forecast (2019-2030)
10.3.4 Argentina ﾂ鮓ｹﾔｭｴｴ Size and Forecast (2019-2030)
11 Middle East & Africa
11.1 Middle East & Africa Oxfendazole Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Oxfendazole Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Oxfendazole ﾂ鮓ｹﾔｭｴｴ Size by Country
11.3.1 Middle East & Africa Oxfendazole Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Oxfendazole Consumption Value by Country (2019-2030)
11.3.3 Turkey ﾂ鮓ｹﾔｭｴｴ Size and Forecast (2019-2030)
11.3.4 Egypt ﾂ鮓ｹﾔｭｴｴ Size and Forecast (2019-2030)
11.3.5 Saudi Arabia ﾂ鮓ｹﾔｭｴｴ Size and Forecast (2019-2030)
11.3.6 South Africa ﾂ鮓ｹﾔｭｴｴ Size and Forecast (2019-2030)
12 ﾂ鮓ｹﾔｭｴｴ Dynamics
12.1 Oxfendazole ﾂ鮓ｹﾔｭｴｴ Drivers
12.2 Oxfendazole ﾂ鮓ｹﾔｭｴｴ Restraints
12.3 Oxfendazole Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of Oxfendazole and Key Manufacturers
13.2 Manufacturing Costs Percentage of Oxfendazole
13.3 Oxfendazole Production Process
13.4 Oxfendazole Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Oxfendazole Typical Distributors
14.3 Oxfendazole Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

Companies Mentioned:

Alivira Animal Health
Bazayan
Wuhan Dahua Pharmaceutical
Jiangsu Baozong & Baoda Pharmachem
Shanxi Hanjiang pharmaceutical
Lasa Laboratory
Jiangsu Quality Horizons Pharmtech

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

ﾌ�

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

ﾌ�

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.